Skip to main content
. 2017 Aug 7;8(39):66305–66315. doi: 10.18632/oncotarget.19985

Figure 3.

Figure 3

(A) Overall survival of the ARTIST patients (n=73) according to the NanoString mesenchymal scores. Solid line, non-mesenchymal (bottom 75% scores). (B) Overall survival of all (ARTIST/ACRG combined) patients (n=143) according to the NanoString mesenchymal scores. Solid line, non-mesenchymal (bottom 75% scores); dotted line, mesenchymal (top 25% scores).